4.7 Review

Emerging roles of peroxisome proliferator-activated receptor-β/δ in inflammation

期刊

PHARMACOLOGY & THERAPEUTICS
卷 124, 期 2, 页码 141-150

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pharmthera.2009.06.011

关键词

Peroxisome proliferator-activated receptor; Inflammation; Transcription factor

资金

  1. British Heart Foundation [PG/08/070/25464]
  2. European Community FP6 [LSHM-CR-20040050333]

向作者/读者索取更多资源

Peroxisome proliferator-activated receptor (PPAR)-beta/delta is a member of the PPAR nuclear hormone receptor family. The PPARs are a family of 3 ligand-activated transcription factors: PPAR alpha (NR1C1), PPAR beta/delta (NR1C2), and PPAR gamma (NR1C3). All the PPARs play important roles in the regulation of metabolic pathways, including those of lipid of biosynthesis and glucose metabolism, as well as in a variety of cell differentiation, proliferation, and apoptosis pathways. Recently, there has been a great deal of interest in the involvement of PPARs in the inflammatory processes. In particular, PPAR alpha and PPAR gamma inhibit the activation of inflammatory gene expression and can negatively interfere with pro-inflammatory transcription factor signalling pathways in vascular and inflammatory cells. In contrast, the roles of PPAR beta/delta regulating inflammation and immunity are only just emerging. This review will focus on these emerging roles of PPAR beta/delta in regulating inflammatory processes. (C) 2009 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据